Hmeljak J, Sanchez-Vega F, Hoadley KA, et al. Integrative Molecular Characterization of Malignant Pleural Mesothelioma. Cancer Discov. 2018;8(12):1548-1565. doi:10.1158/2159-8290.CD-18-0804
Chen LQ, Luo JH, Cui ZH, et al. , , and Encode Putative H3K4 Methyltransferases and Are Critical for Plant Development. Plant Physiol. 2017;174(3):1795-1806. doi:10.1104/pp.16.01944
Shortt J, Ott CJ, Johnstone RW, Bradner JE. A chemical probe toolbox for dissecting the cancer epigenome. Nat Rev Cancer. 2017;17(3):160-183. doi:10.1038/nrc.2016.148
Santos-Rosa H, Schneider R, Bannister AJ, et al. Active genes are tri-methylated at K4 of histone H3. Nature. 2002;419(6905):407-11. doi:10.1038/nature01080
Renneville A, van Galen P, Canver MC, et al. EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression. Blood. 2015;126(16):1930-9. doi:10.1182/blood-2015-06-649087
Singh T, Kurki MI, Curtis D, et al. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. Nat Neurosci. 2016;19(4):571-7. doi:10.1038/nn.4267
Narasimhan VM, Hunt KA, Mason D, et al. Health and population effects of rare gene knockouts in adult humans with related parents. Science. 2016;352(6284):474-7. doi:10.1126/science.aac8624
D’Gama AM, Pochareddy S, Li M, et al. Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. Neuron. 2015;88(5):910-7. doi:10.1016/j.neuron.2015.11.009
Maier VK, Feeney CM, Taylor JE, et al. Functional Proteomic Analysis of Repressive Histone Methyltransferase Complexes Reveals ZNF518B as a G9A Regulator. Mol Cell Proteomics. 2015;14(6):1435-46. doi:10.1074/mcp.M114.044586
Wang J, Iwasaki H, Krivtsov A, et al. Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. EMBO J. 2005;24(2):368-81. doi:10.1038/sj.emboj.7600521